Suppr超能文献

血管内修复腹主动脉瘤是一种有效的替代开放修复的方法,即使在不符合使用说明标准的患者中也是如此。

Endovascular Repair of Abdominal Aortic Aneurysms is a Valid Alternative to Open Repair also in Patients Treated Outside of Instructions for Use Criteria.

机构信息

Department of Vascular and Interventional Radiology, Tampere University Hospital, P.O. BOX 2000, 33521, Tampere, Finland.

Tampere University, 33014, Tampere, Finland.

出版信息

Cardiovasc Intervent Radiol. 2022 Dec;45(12):1765-1773. doi: 10.1007/s00270-022-03297-7. Epub 2022 Nov 4.

Abstract

PURPOSE

It remains unclear whether endovascular aneurysm repair, in the long term, is less effective than open surgery due to need for reinterventions and close monitoring. We aimed to evaluate this matter in a real-life cohort.

METHODS

We collected consecutive patients treated with EVAR or OSR between January 2005 and December 2013. Primary outcomes were 30-day, 90-day and long-term all-cause mortality. Secondary outcomes were 30-day reintervention rate and reintervention-free survival. We evaluated also a subpopulation who did not adhere to IFU.

RESULTS

The inclusion criteria were met by 416 patients. 258 (62%) received EVAR, while 158 (38%) underwent OSR. The 30- or 90-day mortality was similar between groups (p = 0.272 and p = 0.346), as ARM (p = 0.652). The 30-day reintervention rate was higher in the OSR group (p < 0.001), but during follow-up, it was significantly higher in the EVAR group (log-rank: 0.026). There were 114 (44.2%) non-IFU patients in the EVAR group, and we compared them with OSR group. There was no significant difference in all-cause mortality at 30 or 90 days, nor in the long term (p = 1; p = 1 and p = 0.062). ARM was not affected by the procedure technique (p = 0.136). The short-term reintervention rate was higher in the OSR group (p = 0.003), while in the long-term EVAR, patients experienced more reinterventions (log-rank = 0.0.43).

CONCLUSION

No significant difference in survival was found between EVAR and OSR, independent of adherence to IFU. EVAR may be considered for surgical candidates.

摘要

目的

由于需要再次干预和密切监测,血管内动脉瘤修复术(EVAR)的长期效果是否不如开放手术仍不清楚。我们旨在真实队列中评估这一问题。

方法

我们收集了 2005 年 1 月至 2013 年 12 月期间接受 EVAR 或 OSR 治疗的连续患者。主要结局是 30 天、90 天和长期全因死亡率。次要结局为 30 天再干预率和再干预无失败生存率。我们还评估了未遵守 IFU 的亚组人群。

结果

符合纳入标准的患者共 416 例。其中 258 例(62%)接受 EVAR,158 例(38%)接受 OSR。两组间 30 天或 90 天死亡率无差异(p=0.272 和 p=0.346),ARM 也无差异(p=0.652)。OSR 组 30 天再干预率较高(p<0.001),但在随访期间,EVAR 组显著更高(log-rank:0.026)。EVAR 组中有 114 例(44.2%)非 IFU 患者,我们将其与 OSR 组进行比较。两组在 30 天或 90 天的全因死亡率,以及长期死亡率上均无差异(p=1;p=1 和 p=0.062)。ARM 不受手术技术影响(p=0.136)。OSR 组短期再干预率较高(p=0.003),而在长期随访中,EVAR 患者经历了更多的再干预(log-rank=0.0.43)。

结论

无论是否遵守 IFU,EVAR 与 OSR 的生存结果均无显著差异。EVAR 可考虑用于手术候选者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2e9/9705501/d71cf17985a8/270_2022_3297_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验